|
US11583593B2
(en)
|
2016-01-14 |
2023-02-21 |
Synthis Therapeutics, Inc. |
Antibody-ALK5 inhibitor conjugates and their uses
|
|
BR112019000071A2
(pt)
|
2016-07-07 |
2019-07-02 |
Bolt Biotherapeutics Inc |
conjugados adjuvantes de anticorpo
|
|
AU2018273914A1
(en)
|
2017-05-24 |
2019-11-14 |
Pandion Operations, Inc. |
Targeted immunotolerance
|
|
US10946068B2
(en)
|
2017-12-06 |
2021-03-16 |
Pandion Operations, Inc. |
IL-2 muteins and uses thereof
|
|
US10174091B1
(en)
|
2017-12-06 |
2019-01-08 |
Pandion Therapeutics, Inc. |
IL-2 muteins
|
|
BR112020023926A2
(pt)
*
|
2018-05-25 |
2021-02-17 |
Silverback Therapeutics, Inc. |
compostos de amino-pirazinocarboxamida, conjugados e usos dos mesmos
|
|
CN111018857B
(zh)
*
|
2018-10-09 |
2023-06-02 |
嘉兴优博生物技术有限公司 |
靶向蛋白酶降解平台(ted)
|
|
UA128431C2
(uk)
|
2018-11-26 |
2024-07-10 |
Форті Севен, Інк. |
ГУМАНІЗОВАНЕ АНТИТІЛО ДО c-Kit
|
|
EP3937984A1
(en)
|
2019-03-15 |
2022-01-19 |
Bolt Biotherapeutics, Inc. |
Immunoconjugates targeting her2
|
|
EP3725370A1
(en)
|
2019-04-19 |
2020-10-21 |
ImmunoBrain Checkpoint, Inc. |
Modified anti-pd-l1 antibodies and methods and uses for treating a neurodegenerative disease
|
|
CA3139274A1
(en)
*
|
2019-05-10 |
2020-11-19 |
Lyvgen Biopharma Co., Ltd. |
Humanized anti-cd137 antibodies and uses thereof
|
|
AU2020279240A1
(en)
|
2019-05-20 |
2021-12-23 |
Pandion Operations, Inc. |
MAdCAM targeted immunotolerance
|
|
EP3999544A4
(en)
*
|
2019-07-19 |
2023-08-09 |
Wuxi Xdc Singapore Private Limited |
POLYPEPTIDE COMPLEX FOR CONJUGATION AND ITS USE
|
|
EP4008730A4
(en)
*
|
2019-08-02 |
2023-09-06 |
Akeso Pharmaceuticals, Inc. |
BISPECIFIC ANTI-CTLA4-ANTI-PD-1 ANTIBODY AND ITS USES
|
|
WO2021102332A1
(en)
*
|
2019-11-22 |
2021-05-27 |
Silverback Therapeutics, Inc. |
Tgfbetar2 inhibitor-lrrc15 antibody conjugates and uses thereof
|
|
EP4041769A1
(en)
*
|
2019-12-12 |
2022-08-17 |
The United States of America, as represented by the Secretary, Department of Health and Human Services |
Antibody-drug conjugates specific for cd276 and uses thereof
|
|
CN115052663B
(zh)
*
|
2020-01-08 |
2026-06-09 |
辛瑟斯治疗股份有限公司 |
Alk5抑制剂缀合物及其用途
|
|
TWI854088B
(zh)
*
|
2020-01-27 |
2024-09-01 |
英商梅迪繆思有限公司 |
用於治療腎臟疾病之抗αvβ8整聯蛋白抗體
|
|
US11981715B2
(en)
|
2020-02-21 |
2024-05-14 |
Pandion Operations, Inc. |
Tissue targeted immunotolerance with a CD39 effector
|
|
US11179473B2
(en)
|
2020-02-21 |
2021-11-23 |
Silverback Therapeutics, Inc. |
Nectin-4 antibody conjugates and uses thereof
|
|
CN115379848A
(zh)
*
|
2020-04-01 |
2022-11-22 |
加利福尼亚大学董事会 |
靶向间充质干细胞衍生的癌细胞和间充质干细胞相关疾病的免疫治疗诊断剂
|
|
CN113509557A
(zh)
*
|
2020-04-09 |
2021-10-19 |
嘉兴优博生物技术有限公司 |
靶向蛋白酶降解平台(ted)
|
|
WO2021231922A1
(en)
*
|
2020-05-14 |
2021-11-18 |
The General Hospital Corporation |
Agonistic tumor necrosis factor receptor superfamily polypeptides
|
|
WO2021243136A2
(en)
*
|
2020-05-29 |
2021-12-02 |
New York Society For The Relief Of The Ruptured And Crippled, Maintaining The Hospital For Special Surgery |
Methods and compositions for treating, preventing the onset and/or slowing progression of osteoarthritis
|
|
EP4157883A4
(en)
*
|
2020-06-02 |
2024-12-04 |
Children's Medical Center Corporation |
NANOBODY CONJUGATES (VHH) AND THEIR USES
|
|
CN117083079A
(zh)
*
|
2020-06-02 |
2023-11-17 |
儿童医学中心公司 |
纳米抗体(vhh)缀合物及其用途
|
|
KR20230047361A
(ko)
|
2020-07-01 |
2023-04-07 |
아르스 파마슈티컬스 인크. |
항-asgr1 항체 접합체 및 이의 용도
|
|
KR102506295B1
(ko)
*
|
2020-08-28 |
2023-03-08 |
국립암센터 |
디그옥시제닌에 대한 인간화 항체 및 이의 용도
|
|
CN114146095A
(zh)
*
|
2020-09-07 |
2022-03-08 |
是光隽恒(北京)生物科技有限公司 |
用于组织损伤修复的组合物及其制备方法和用途
|
|
WO2022053864A1
(en)
*
|
2020-09-08 |
2022-03-17 |
Kwon Byoung S |
Pd-1 polypeptide variants
|
|
GB202104935D0
(en)
*
|
2021-04-07 |
2021-05-19 |
Hummingbird Bioscience Holdings Pte Ltd |
BCMA/TACI antigen-binding molecules
|
|
WO2022109105A1
(en)
*
|
2020-11-18 |
2022-05-27 |
Pandion Operations, Inc. |
Madcam targeted therapeutics and uses thereof
|
|
AU2022254042A1
(en)
*
|
2021-04-07 |
2023-09-14 |
Mythic Therapeutics, Inc. |
Antigen-binding protein constructs and antibodies and uses thereof
|
|
WO2022217022A1
(en)
|
2021-04-10 |
2022-10-13 |
Profoundbio Us Co. |
Folr1 binding agents, conjugates thereof and methods of using the same
|
|
CA3216459A1
(en)
|
2021-04-23 |
2022-10-27 |
Profoundbio Us Co. |
Anti-cd70 antibodies, conjugates thereof and methods of using the same
|
|
JP2024526259A
(ja)
|
2021-07-02 |
2024-07-17 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツング |
抗protac抗体および複合体
|
|
TW202320857A
(zh)
|
2021-07-06 |
2023-06-01 |
美商普方生物製藥美國公司 |
連接子、藥物連接子及其結合物及其使用方法
|
|
US20250043005A1
(en)
*
|
2021-12-09 |
2025-02-06 |
Genequantum Healthcare (Suzhou) Co., Ltd. |
Antibody-cytokine fusion proteins and applications thereof
|
|
EP4458830A4
(en)
*
|
2021-12-30 |
2025-12-03 |
Sichuan Kelun Biotech Biopharmaceutical Co Ltd |
TRICYCLIC COMPOUND, ITS PREPARATION PROCESS AND ITS USE
|
|
CA3262796A1
(en)
*
|
2022-09-20 |
2024-03-28 |
Currus Biologics Pty Ltd |
Bispecific Polypeptides and Their Uses
|
|
CN120417934A
(zh)
*
|
2022-12-23 |
2025-08-01 |
基因泰克公司 |
Cereblon降解剂缀合物及其用途
|
|
IL321713A
(en)
|
2022-12-27 |
2025-08-01 |
Merck Patent Gmbh |
Anti-PROTAC VHH antibodies and complexes
|
|
WO2024200987A1
(en)
*
|
2023-03-31 |
2024-10-03 |
Avacta Life Sciences Limited |
Tnfr2 binding polypeptides and methods of use
|
|
FR3147278A1
(fr)
*
|
2023-03-31 |
2024-10-04 |
Avacta Life Sciences Limited |
Polypeptides de liaison au tnfr2 et procedes d'utilisation
|
|
FR3147292A1
(fr)
*
|
2023-03-31 |
2024-10-04 |
Affyxell Therapeutics Co., Ltd. |
Cellules genetiquement modifiees dans lesquelles un acide nucleique codant pour des variantes de la proteine stefine a se liant specifiquement au tnfr2 ou une proteine de fusion comprenant celle-ci a ete introduite, et leurs utilisations
|
|
KR20260023524A
(ko)
*
|
2023-05-18 |
2026-02-20 |
파이어플라이 바이오, 인크. |
이소인돌리논-글루타르이미드 항체 접합체 및 이의 용도
|
|
WO2024243545A1
(en)
*
|
2023-05-24 |
2024-11-28 |
President And Fellows Of Harvard College |
Compositions targeting endothelial cells and uses thereof
|
|
AR133955A1
(es)
|
2023-09-26 |
2025-11-19 |
Profoundbio Us Co |
Agentes de unión a ptk7, conjugados de éstos y métodos de uso de los mismos
|
|
TW202547866A
(zh)
|
2024-01-10 |
2025-12-16 |
丹麥商珍美寶股份有限公司 |
Slitrk6結合劑、其共軛物及使用彼之方法
|
|
WO2025163120A1
(en)
*
|
2024-02-01 |
2025-08-07 |
Adcytherix Sas |
ANTIBODY-DRUG CONJUGATES COMPRISING AN ANTI-INTEGRIN ΑVβ6 BINDING ANTIBODY
|
|
EP4595981A1
(en)
*
|
2024-02-01 |
2025-08-06 |
Jack Elands |
Antibody-drug conjugates comprising an anti-integrin v 6 binding antibody
|
|
WO2025181219A1
(en)
|
2024-02-29 |
2025-09-04 |
Genmab A/S |
Egfr and c-met bispecific binding agents, conjugates thereof and methods of using the same
|
|
WO2025216667A1
(en)
*
|
2024-04-12 |
2025-10-16 |
Joint Stock Company «Biocad» |
Monoclonal antibody that specifically binds to bdca-2
|
|
WO2026093513A1
(en)
|
2024-10-31 |
2026-05-07 |
Sotio Biotech A.S. |
Anti-lrrc15 antibodies and uses thereof
|